Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in IDXX — Idexx Laboratories Inc /De

CIK 861177 NEW YORK, NY

Position in IDXX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$489,849,516
-$91,889,829 QoQ
Shares Held
871,789
+1.4% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 55.71462819558403.ToString("F0")% Shared 0.ToString("F0")% None 44.28537180441598.ToString("F0")%

Common Shares in IDXX Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,972,110,878 across 32 Diagnostics & Research names. IDXX ranks #3 (9.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 IDXX
Idexx Laboratories Inc /De
This page
871,789 $489,849,516

All Filings in IDXX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $489,849,516 871,789
2025-12-31 $581,739,345 859,887
2025-09-30 $559,379,495 875,549
2025-06-30 $573,937,425 1,070,100
2025-03-31 $452,046,350 1,076,429
2024-12-31 $324,913,394 785,878
2024-09-30 $379,874,912 751,900
2024-06-30 $365,125,701 749,437
2024-03-31 $288,653,592 534,613
2023-12-31 $303,516,320 546,827
2023-09-30 $220,729,079 504,789
2023-06-30 $209,733,252 417,604
2023-03-31 $208,835,402 417,604
2022-12-31 $169,858,219 416,360
2022-09-30 $135,370,221 415,501
2022-06-30 $151,421,009 431,731
2022-03-31 $255,525,156 467,088
2021-12-31 $297,552,801 451,892
2021-09-30 $275,076,937 442,317
2021-06-30 $273,924,703 433,734
2021-03-31 $207,871,604 424,826
2020-12-31 $209,536,000 419,181
2020-09-30 $144,919,212 368,648
2020-06-30 $118,749,303 359,672
2020-03-31 $93,002,473 383,927